(BLX) Foreign Trade Bank of Latin - Ratings and Ratios
Trade, Loans, Guarantees, Leasing, Investments
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 6.01% |
| Yield on Cost 5y | 21.97% |
| Yield CAGR 5y | 25.74% |
| Payout Consistency | 82.3% |
| Payout Ratio | 41.6% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 27.1% |
| Value at Risk 5%th | 41.9% |
| Relative Tail Risk | -5.91% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.05 |
| Alpha | 16.17 |
| CAGR/Max DD | 2.40 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.471 |
| Beta | 0.725 |
| Beta Downside | 0.802 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.01% |
| Mean DD | 4.32% |
| Median DD | 3.46% |
Description: BLX Foreign Trade Bank of Latin January 16, 2026
Banco Latinoamericano de Comercio Exterior (BLX) is a Panama-headquartered multinational bank that finances foreign-trade and economic integration across Latin America and the Caribbean. It operates through Commercial and Treasury segments, accepts deposits, and provides a suite of trade-finance products-including bilateral loans, syndicated credits, letters of credit, guarantees, factoring, vendor financing, and leasing-while also managing investment securities for a client base that spans financial institutions, corporates, sovereigns, and state-owned entities.
As of the latest filing, BLX reported total assets of roughly US$6.4 billion and a loan-to-deposit ratio of 78%, indicating a solid funding base. The bank’s net interest margin has hovered near 4.2% in 2023, supported by strong regional trade growth-Latin American intra-regional trade volumes rose about 5% year-over-year, boosting demand for structured trade financing. Additionally, BLX maintains a capital adequacy ratio of 15.1%**, well above the Basel III minimum, and its exposure is concentrated in commodities-linked sectors (e.g., oil, mining), making commodity price cycles a key driver of earnings volatility.
For a deeper quantitative view of BLX’s risk-adjusted performance, you might explore ValueRay’s analytics platform.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 222.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 10.61 > 1.0 |
| NWC/Revenue: -637.7% < 20% (prev -598.9%; Δ -38.81% < -1%) |
| CFO/TA 0.07 > 3% & CFO 834.3m > Net Income 222.4m |
| Net Debt (3.56b) to EBITDA (226.5m): 15.69 < 3 |
| Current Ratio: 0.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (37.2m) vs 12m ago 1.21% < -2% |
| Gross Margin: 35.90% > 18% (prev 0.51%; Δ 3539 % > 0.5%) |
| Asset Turnover: 6.84% > 50% (prev 7.24%; Δ -0.40% > 0%) |
| Interest Coverage Ratio: 0.44 > 6 (EBITDA TTM 226.5m / Interest Expense TTM 507.6m) |
Altman Z'' -2.22
| A: -0.42 (Total Current Assets 2.19b - Total Current Liabilities 7.40b) / Total Assets 12.50b |
| B: 0.07 (Retained Earnings 891.3m / Total Assets 12.50b) |
| C: 0.02 (EBIT TTM 222.4m / Avg Total Assets 11.95b) |
| D: 0.15 (Book Value of Equity 1.62b / Total Liabilities 10.85b) |
| Altman-Z'' Score: -2.22= D |
Beneish M -2.81
| DSRI: 0.89 (Receivables 108.4m/123.7m, Revenue 817.9m/826.7m) |
| GMI: 1.41 (GM 35.90% / 50.57%) |
| AQI: 0.99 (AQ_t 0.82 / AQ_t-1 0.83) |
| SGI: 0.99 (Revenue 817.9m / 826.7m) |
| TATA: -0.05 (NI 222.4m - CFO 834.3m) / TA 12.50b) |
| Beneish M-Score: -2.81 = A |
ValueRay F-Score (Strict, 0-100) 60.53
| 1. Piotroski: 5.0pt |
| 2. FCF Yield: 25.84% |
| 3. FCF Margin: data missing |
| 4. Debt/Equity: 2.16 |
| 5. Debt/Ebitda: 15.69 |
| 6. ROIC - WACC: -1.32% |
| 7. RoE: 15.42% |
| 8. Revenue Trend: 83.16% |
| 9. EPS Trend: 32.63% |
What is the price of BLX shares?
Over the past week, the price has changed by +5.40%, over one month by +7.85%, over three months by +6.38% and over the past year by +32.88%.
Is BLX a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BLX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 55.5 | 17% |
| Analysts Target Price | 55.5 | 17% |
| ValueRay Target Price | 71.2 | 50.2% |
BLX Fundamental Data Overview January 22, 2026
P/S = 5.3513
P/B = 1.0182
P/EG = 1.58
Revenue TTM = 817.9m USD
EBIT TTM = 222.4m USD
EBITDA TTM = 226.5m USD
Long Term Debt = 2.34b USD (from longTermDebt, last quarter)
Short Term Debt = 139.4m USD (from shortTermDebt, last quarter)
Debt = 3.56b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.56b USD (from netDebt column, last quarter)
Enterprise Value = 3.22b USD (1.63b + Debt 3.56b - CCE 1.96b)
Interest Coverage Ratio = 0.44 (Ebit TTM 222.4m / Interest Expense TTM 507.6m)
EV/FCF = 3.87x (Enterprise Value 3.22b / FCF TTM 832.9m)
FCF Yield = 25.84% (FCF TTM 832.9m / Enterprise Value 3.22b)
FCF Margin = 101.8% (FCF TTM 832.9m / Revenue TTM 817.9m)
Net Margin = 27.19% (Net Income TTM 222.4m / Revenue TTM 817.9m)
Gross Margin = 35.90% ((Revenue TTM 817.9m - Cost of Revenue TTM 524.3m) / Revenue TTM)
Gross Margin QoQ = 36.50% (prev 39.23%)
Tobins Q-Ratio = 0.26 (Enterprise Value 3.22b / Total Assets 12.50b)
Interest Expense / Debt = 3.55% (Interest Expense 126.3m / Debt 3.56b)
Taxrate = 21.0% (US default 21%)
NOPAT = 175.7m (EBIT 222.4m * (1 - 21.00%))
Current Ratio = 0.30 (Total Current Assets 2.19b / Total Current Liabilities 7.40b)
Debt / Equity = 2.16 (Debt 3.56b / totalStockholderEquity, last quarter 1.65b)
Debt / EBITDA = 15.69 (Net Debt 3.56b / EBITDA 226.5m)
Debt / FCF = 4.27 (Net Debt 3.56b / FCF TTM 832.9m)
Total Stockholder Equity = 1.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.86% (Net Income 222.4m / Total Assets 12.50b)
RoE = 15.42% (Net Income TTM 222.4m / Total Stockholder Equity 1.44b)
RoCE = 5.88% (EBIT 222.4m / Capital Employed (Equity 1.44b + L.T.Debt 2.34b))
RoIC = 3.30% (NOPAT 175.7m / Invested Capital 5.33b)
WACC = 4.62% (E(1.63b)/V(5.18b) * Re(8.59%) + D(3.56b)/V(5.18b) * Rd(3.55%) * (1-Tc(0.21)))
Discount Rate = 8.59% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.94%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈832.9m ; Y1≈546.7m ; Y5≈249.5m
Fair Price DCF = 152.9 (EV 7.95b - Net Debt 3.56b = Equity 4.39b / Shares 28.7m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 32.63 | EPS CAGR: -28.18% | SUE: 0.0 | # QB: 0
Revenue Correlation: 83.16 | Revenue CAGR: 66.98% | SUE: 4.0 | # QB: 9
EPS next Year (2026-12-31): EPS=6.67 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+7.6% | Growth Revenue=+6.6%
Additional Sources for BLX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle